Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Press Releases
Biosimilars Council Press Releases
Press Releases
Press Releases
June 3, 2025
AAM
Generic and Biosimilar Patent Settlements Save $423 Billion
Press Releases
April 14, 2025
AAM
AAM Comments on Section 232 Investigation on Pharmaceuticals
Press Releases
April 14, 2025
AAM
AAM Commends Senate Q1/Q2 Bill Introduction
Press Releases
April 3, 2025
AAM
AAM Congratulates Dr. Oz on Confirmation as Administrator of the Centers for Medicare & Medicaid Services
Press Releases
April 1, 2025
AAM
AAM Comments on staff layoffs at FDA
Press Releases
March 27, 2025
AAM
AAM Congratulates FDA Commissioner Makary
Press Releases
March 7, 2025
AAM
AAM Commends Q1/Q2 House Bill Reintroduction
Press Releases
February 13, 2025
AAM
Association for Accessible Medicines on Confirmation of Robert F. Kennedy Jr. as Secretary of Health and Human Services
Press Releases
February 4, 2025
AAM
Association for Accessible Medicines 2025 Advocacy Priorities
Press Releases
February 2, 2025
AAM
Association for Accessible Medicines Comments on New Tariffs
Press Releases
January 22, 2025
AAM
Keren Haruvi Reelected Chair of the Association for Accessible Medicines Board of Directors
Press Releases
January 17, 2025
AAM
AAM Comments on Medicare Drug Price Negotiation List
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH